FDA Inspection 1073448 — Andres Emanuelli, M.D.
The FDA completed an inspection of Andres Emanuelli, M.D. on October 11, 2018 in Arecibo, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 11, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Arecibo, PR (United States)
Additional Details
Clinical Investigator (CI)